KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) FCF Payout Ratio (2016 - 2025)

Historic FCF Payout Ratio for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to 1.98.

  • Eli Lilly's FCF Payout Ratio rose 6615.68% to 1.98 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.6, marking a year-over-year decrease of 5178.77%. This contributed to the annual value of 0.6 for FY2025, which is 5178.77% down from last year.
  • As of Q4 2025, Eli Lilly's FCF Payout Ratio stood at 1.98, which was up 6615.68% from 0.2 recorded in Q3 2025.
  • Over the past 5 years, Eli Lilly's FCF Payout Ratio peaked at 8.62 during Q1 2025, and registered a low of 9.57 during Q2 2023.
  • Its 5-year average for FCF Payout Ratio is 1.06, with a median of 0.68 in 2022.
  • Its FCF Payout Ratio has fluctuated over the past 5 years, first crashed by 98011.78% in 2023, then surged by 57935.97% in 2024.
  • Over the past 5 years, Eli Lilly's FCF Payout Ratio (Quarter) stood at 0.39 in 2021, then skyrocketed by 93.92% to 0.76 in 2022, then crashed by 196.69% to 0.74 in 2023, then skyrocketed by 262.32% to 1.19 in 2024, then soared by 66.16% to 1.98 in 2025.
  • Its last three reported values are 1.98 in Q4 2025, 0.2 for Q3 2025, and 0.97 during Q2 2025.